OICHARTS
8 AMThe 8 AM report →

ELV

Elevance Health, Inc. · XNYS · 131 sessions on record
$388.82▼ −3.91 · −1.0%from $392.73 the session before · Sep 30, 2026 close · end of day
Open
$391.91
High
$396.14
Low
$383.04
Day's range
$133.3% of the previous close
VWAP
$390.81close −0.51% from it
Volume, shares
1.3M1.04× the 20-session average
Traded, $
$509.5M
Trades
34.2K38 shares per trade
Previous close
$392.73−3.91 to the close
Market cap
$84.32Bat the close of Sep 30
Day range44% of the way up
$383.04$396.14
52-week range69% of the way up
$282.46 Mar 27$436.24 Jul 14

−11% from the high · +38% from the low

Options

No listed options on ELV

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
ELV close over the last 126 sessions, with S&P 500 rebased to the first close298.50362.64426.79axis spans 43%S&P 500ELVApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 43 percent.

Quarterly results

consolidated · latest filed Jul 15, 2026 · SEC filings

Revenue $50.47B, +1.4% on a year earlier; profit $1.46B, −16% in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of ELV on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Jul 15$50.47B▲ +1.4%$1.46B▼ −16%6.71▼ −4.5%S&P 500 −0.5% · −3.9 pp
Mar 2026filed Apr 22$50.18B▲ +2.6%$1.76B▼ −19%8.00▲ +5.5%S&P 500 −0.4% · +5.9 pp
Dec 2025filed Feb 6$49.75B▲ +9.5%$547.0M▲ +31%2.56—not reached
Sep 2025filed Oct 21$50.71B▲ +12%$1.19B▲ +17%5.32—not reached
Jun 2025filed Jul 15$49.78B▲ +13%$1.74B▼ −24%7.72▼ −4.5%S&P 500 −0.5% · −3.9 pp
Mar 2025filed Apr 22$48.89B▲ +15%$2.18B▼ −2.8%9.61▲ +5.5%S&P 500 −0.4% · +5.9 pp
Dec 2024filed Feb 20$45.44B▲ +6.6%$418.0M▼ −51%1.88—not reached
Sep 2024filed Oct 21$45.11B▲ +5.3%$1.02B▼ −21%4.36—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of ELV on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025$199.13B▲ +12%$5.66B▼ −5.3%25.21
FY24to Dec 2024$177.01B▲ +3.3%$5.98B▼ −0.12%25.68
FY23to Dec 2023$171.34B▲ +9.4%$5.99B▲ +1.6%25.22
FY22to Dec 2022$156.59B▲ +13%$5.89B▼ −4.3%24.28
FY21to Dec 2021$138.64B▲ +14%$6.16B▲ +35%24.95

Fundamentals

consolidated · filings to Jun 2026 · close $388.82 on Sep 30

ELV trades at 17 times trailing earnings, 1.9 times book value, revenue +6.3% over twelve months, a 0.88% dividend yield, market cap $84.32B.

Valuation
Market cap
$84.32Bon Sep 30
Price to earnings
17consolidated · four quarters to Jun 2026
Trailing EPS
$22.59diluted · consolidated · four quarters to Jun 2026
Price to book
1.9consolidated · balance sheet to Jun 2026
Book value a share
$206.96consolidated · balance sheet to Jun 2026
Debt to equity
0.69borrowings over equity · consolidated · balance sheet to Jun 2026
Return on equity
11%trailing profit over average equity · consolidated
Dividend yield
0.88%$3.44 a share in 365 days
Price to sales
0.42market cap over revenue, four quarters to Jun 2026
Shares outstanding
217Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$201.11Bfour quarters to Jun 2026
Revenue growth, 12 months
▲ +6.3%against the twelve months before
Revenue 3-year CAGR
▲ +6.7%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
$4.96Bfour quarters to Jun 2026
Profit growth, 12 months
▼ −7.4%against the twelve months before
Profit 3-year CAGR
▼ −8.3%trailing twelve months against the twelve months 3 years earlier · consolidated

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 170% of shares, BlackRock, Inc. the largest at 18%, VANGUARD CAPITAL MANAGEMENT LLC 13% and STATE STREET CORP 9.6%, as filed for the quarter to Jun 2026.

Held by 13F managers
170%of shares outstanding
Shares held
378M−0.62% on Mar 2026 among managers filing both
Managers holding
1,5181,384 a quarter earlier
Largest holder
18%BlackRock, Inc.
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of ELV
ManagerSharesOf outstandingValueChange on quarter
BlackRock, Inc.38M18%$14.69B−1.79M
VANGUARD CAPITAL MANAGEMENT LLC28.1M13%$10.87B−575K
STATE STREET CORP20.9M9.6%$8.06B+276K
WELLINGTON MANAGEMENT GROUP LLP18.4M8.5%$7.13B+1.97M
VANGUARD PORTFOLIO MANAGEMENT LLC12.4M5.7%$4.81B−283K
Sanders Capital, LLC11.7M5.4%$4.51B−139K
GEODE CAPITAL MANAGEMENT, LLC10.3M4.8%$3.98B−53.2K
HARRIS ASSOCIATES L P9.85M4.5%$3.81B+256K
Artisan Partners Limited Partnership9.16M4.2%$3.54B−1.09M
Invesco Ltd.8.47M3.9%$3.28B−1.17M
Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

ELV insider trades
InsiderTradeSharesPriceHeld after
Penczek Ronald WOfficersold · Jun 12, 2026369$403.163,740
Dixon Robert L JRDirectorsold · Jun 11, 2026151$401.7710,734
Penczek Ronald WOfficerexercised · May 19, 2026877$311.485,640
Penczek Ronald WOfficersold · May 19, 20261,531$403.134,109
Penczek Ronald WOfficerexercised · May 19, 2026654$271.274,763
HAY LEWIS IIIDirectorgranted · May 13, 2026563$0.0012,070
COLLIS STEVEN HDirectorgranted · May 13, 2026563$0.004,202
PERU RAMIRO GDirectorgranted · May 13, 2026563$0.009,908
Schneider Ryan M.Directorgranted · May 13, 2026563$0.007,163
SCHULMAN AMY WDirectorgranted · May 13, 2026563$0.00781

Corporate actions

exchange records

Nothing upcoming on record; the last was a dividend of $1.72 a share, ex-date Sep 10, 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in dollars a share, splits as ratios
Corporate actions of ELV, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord date
recent
Sep 10, 2026dividend$1.72—
Jun 10, 2026dividend$1.72—
Calendardividends by ex-date
Dividends in 365 days
$3.44a share · ex-dates inside the year
Last dividend
$1.72ex-date Sep 10, 2026

Price history

131 sessions on record · to Sep 30 · end of day

ELV is −3.5% over 20 sessions against the S&P 500's +0.1%, 11% below its 52-week high, realised volatility 25% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $ELV %S&P 500 %Difference pp
120 sessionssince Apr 9$316.86▲ +23%▲ +12%+11
60 sessionssince Jul 7$418.85▼ −7.2%▲ +2.0%−9.2
20 sessionssince Sep 1$403.05▼ −3.5%▲ +0.11%−3.6
5 sessionssince Sep 23$398.54▼ −2.4%▼ −0.67%−1.8
1 sessionsince Sep 29$392.75▼ −1.0%▼ −0.21%−0.79
Averages of the closeclose against each average
5-session average
$394.10close −1.3% from it
20-session average
$406.13close −4.3% from it
50-session average
$397.22close −2.1% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$8.92.3% of the close
Average day's range, 20
$9.12.3% of the close
Volume against 20 sessions
1.04×1.3M vs 1.26M average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
25%≈ ±1.6% a session · moved more than that on 5 of 20
Realised volatility, 60
32%≈ ±2.0% a session · moved more than that on 14 of 60
Beta to S&P 500, 60
0.38moved with S&P 500 on 38 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
6 up · 14 downof 20
Last 60 sessions
28 up · 32 downof 60
Best session, 250
▲ +7.6%Jul 1
Worst session, 250
▼ −8.5%Jul 15

Elevance Health, Inc. is held by

1 headlines on ELV

latest Sep 25, 2026 · links go to the publisher

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 49% of reported volume on Sep 30, 2026, against 56% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
ELV daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 2026215K442K48.5%
Sep 29, 2026159K306K51.9%
Sep 28, 2026226K458K49.4%
Sep 25, 2026215K474K45.4%
Sep 24, 2026205K458K44.7%
Sep 23, 2026176K475K37.1%
Sep 22, 2026182K397K45.9%
Sep 21, 2026178K284K62.6%
Sep 18, 2026154K304K50.7%
Sep 17, 2026219K533K41.1%

Filings

SEC EDGAR · newest first
ELV SEC filings
FiledFormReport date
Sep 10, 20268-KSep 10, 2026
Sep 4, 20264Sep 2, 2026
Sep 4, 20264Sep 2, 2026
Jul 17, 20264Jul 17, 2026
Jul 17, 20264Jul 17, 2026
Jul 15, 202610-QJun 30, 2026
Jul 15, 20268-KJul 15, 2026
Jul 7, 2026144—
Jun 17, 202611-KDec 31, 2025
Jun 17, 202611-KDec 31, 2025
Jun 15, 20264Jun 12, 2026
Jun 12, 2026144—
Jun 12, 20264Jun 11, 2026
Jun 11, 2026144—
Jun 10, 20268-KJun 10, 2026
May 20, 20264May 19, 2026
May 19, 2026144—
May 15, 20264May 13, 2026
May 15, 20264May 13, 2026
May 15, 20264May 13, 2026
May 15, 20264May 13, 2026
May 15, 20264May 13, 2026
May 15, 20264May 13, 2026
May 15, 20264May 13, 2026
May 15, 20264May 13, 2026

About Elevance Health, Inc.

SEC and exchange records
Company
Elevance Health, Inc.
Exchange
XNYS
SEC CIK
1156039
Sessions on record
131
Price source
End of day · delayed
Computed
2 Oct, 01:46 am IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.